JOSE TOVAR: Open Payments
NPI 1568775641 · PALM SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 14 payments from 8 companies in 2025. Trend: 2023 $1,063 · 2024 $640 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 2 | $155 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Novo Nordisk Inc | 2 | $49 |
| Fresenius USA Marketing, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| AKEBIA THERAPEUTICS INC | 1 | $23 |
| Vifor Pharma, Inc. | 1 | $22 |
| Medtronic, Inc. | 1 | $14 |
Products named: XPHOZAH 30 MG, Ozempic, VELPHORO, Kerendia, IBSRELA, Vafseo, Veltassa, FARXIGA.
Industry payments across CA — which companies pay providers there.
